Go to the list of all blogs
Allana's Avatar
published in Blogs
Oct 12, 2018
Canadian Cannabis Company Aprhia Sees Profit in Q1

Canadian Cannabis Company Aprhia Sees Profit in Q1

Aphria Inc., the Canadian cannabis company that has reportedly been in talks to receive an investment from tobacco giant Altria Group (MO), reported a first quarter profit of C$21.2 million, up from the C$15 million it reported in the same quarter last year.

In a news release, the company said its profit came to nine cents per diluted share compared with a profit of $0.10 per diluted share in the same quarter last year, when it had fewer shares outstanding. Aphria attributed its growth to investments in Liberty Health Sciences and Hiku Brands Co. Ltd., and an increase in fair value of biological assets caused by a production increase.

Although it has not confirmed or denied the rumors of Altria's investment, Aphria shares (traded on the Canadian TSE stock exchange) have been trading higher since the report and its profit announcement. 

Related Ticker: MO

Contributor

Allana's AvatarAllana|Expert

Financial analyst and market blogger with expertise in equity research, fundamental analysis, and macroeconomic trends. I regularly publish coverage on individual stocks, ETFs, and sector developments — combining rigorous financial analysis with clear, engaging writing for a broad investment audience.


MO's MACD Histogram crosses above signal line

The Moving Average Convergence Divergence (MACD) for MO turned positive on August 21, 2026. Looking at past instances where MO's MACD turned positive, the stock continued to rise in 28 of 46 cases over the following month. The odds of a continued upward trend are 61%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where MO's RSI Indicator exited the oversold zone, 13 of 23 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 57%.

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 32 of 55 cases where MO's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 58%.

The Momentum Indicator moved above the 0 level on September 11, 2026. You may want to consider a long position or call options on MO as a result. In 46 of 80 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 57%.

Following a +1.61% 3-day Advance, the price is estimated to grow further. Considering data from situations where MO advanced for three days, in 216 of 387 cases, the price rose further within the following month. The odds of a continued upward trend are 56%.

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where MO declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 37%.

The Aroon Indicator for MO entered a downward trend on August 26, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is 8 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 8 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 67, placing this stock better than average.

The Tickeron Valuation Rating of 21 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (19.382). P/E Ratio (14.522) is within average values for comparable stocks, (23.474). Projected Growth (PEG Ratio) (2.643) is also within normal values, averaging (3.758). Dividend Yield (0.062) settles around the average of (0.048) among similar stocks. MO's P/S Ratio (5.653) is slightly higher than the industry average of (2.805).

The Tickeron PE Growth Rating for this company is 29 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 47 (best 1 - 100 worst), indicating steady price growth. MO’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

Notable companies

The most notable companies in this group are Philip Morris International (NYSE:PM), Altria Group (NYSE:MO).

Industry description

The industry is engaged in the growth, preparation for sale, advertisement, and distribution of tobacco and tobacco-related products like cigarettes. In 2017, tobacco companies spent an estimated $9.36 billion marketing cigarettes and smokeless tobacco in the U.S. – an amount that translates to more than $25 million each day (according to a CDC report). Philip Morris International Inc., Altria Group Inc., and British American Tobacco plc are some major cigar makers. In recent times, vaping or the use of e-cigarette (does not burn tobacco) is gaining momentum – several established cigarette makers are trying to expand their footprint in this new market.

Market Cap

The average market capitalization across the Tobacco Industry is 53.82B. The market cap for tickers in the group ranges from 99 to 297.79B. PM holds the highest valuation in this group at 297.79B. The lowest valued company is AHII at 99.

High and low price notable news

The average weekly price growth across all stocks in the Tobacco Industry was -4%. For the same Industry, the average monthly price growth was -8%, and the average quarterly price growth was -15%. PM experienced the highest price growth at 5%, while XXII experienced the biggest fall at -19%.

Volume

The average weekly volume growth across all stocks in the Tobacco Industry was 23%. For the same stocks of the Industry, the average monthly volume growth was 18% and the average quarterly volume growth was 1%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 39
P/E Growth Rating: 53
Price Growth Rating: 66
SMR Rating: 73
Profit Risk Rating: 67
Seasonality Score: -52 (-100 ... +100)
View a ticker or compare two or three
MO
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a holding company which produces and markets tobacco products

Industry Tobacco

Profile
Details
Industry
Tobacco
Address
6601 West Broad Street
Phone
+1 804 274-2200
Employees
5900
Web
https://www.altria.com
Interact to see
Advertisement
AVAV shares dropped approximately 10% in premarket trading on March 11, 2026, following a disappointing Q3 fiscal 2026 earnings report released after the prior session's close. Q3 revenue of $408.0 million came in far below analyst consensus of approximately $475–$488 million, representing a massive top-line miss.
KOS shares are down approximately 20% in premarket trading on March 11, 2026, having shed roughly 20.31% across the last two sessions (Tuesday close and premarket Wednesday). The primary catalyst is Kosmos Energy's announcement of a massive $185.25 million public equity offering priced at $1.90 per share — a steep discount to recent trading levels.
NBIS shares surged approximately +10% in premarket trading on March 11, 2026, from a prior close of $96.32. The primary catalyst is the imminent addition of Nebius Group to the Bloomberg 500 (B500) Index, effective prior to the open of trading on Thursday, March 12, 2026.
ORCL shares surged approximately +10.49% in Wednesday's premarket session, trading around $165.07 versus Tuesday's closing price of $149.40. The primary catalyst is Oracle's Q3 FY2026 earnings beat, with adjusted EPS of $1.79 vs. the $1.70 consensus estimate, and revenue of $17.2 billion topping the $16.92 billion forecast.
Shares of AngloGold Ashanti plc (AU) are down approximately 5.00% in early trading on March 11, 2026, falling from a prior close of $108.26 to around $102.85. The primary driver is a renewed pullback in gold prices, which has weighed heavily on gold mining equities across the board.
HMY shares are trading down approximately 13% in early session trading on March 11, 2026, following the release of the company's H1 FY26 interim results. Revenue of R44.4 billion (~US$2.6 billion) missed analyst consensus estimates of R47.56 billion, a significant shortfall that spooked investors.
FICO fell over 9% today, extending a multi‑week downtrend that has already knocked the stock more than 7% lower since its last earnings update. The decline comes despite strong recent financial results, including double‑digit revenue growth, expanding margins, and repeated earnings beats.
RERE fell roughly 10% today, giving back a portion of its strong gains over the past year and month, as traders reacted to fresh earnings and guidance. The company delivered robust Q4 2025 results, with revenue growth near 30% year over year and earnings per share ahead of consensus estimates, underscoring continued operational momentum.
Top hedge funds like Millennium, Citadel, and Bridgewater showed limited direct accumulation of penny stocks in Q4 2025 13F filings, but rotations into biotech, energy, and defense sectors highlight indirect interest in low-priced plays under $5. New entries and increased positions focused on volatile sectors like biotech (e.g., ABCL) and energy (e.g., AMPY), with full exits from overvalued names signaling a hunt for undervalued pennies amid market uncertainty.
Penny stocks in the oil sector are exploding in trading volume amid a massive oil price rally, with the USO ETF hitting a record $12.4 billion in daily trades—up 1,000% YTD and surpassing peaks from 2020, 2022, and 2025. Geopolitical tensions from the ongoing Iran war are driving oil above $100 per barrel, creating supply shocks and opportunities for high-volatility plays in exploration, drilling, and production.
NTSK shares are trading down approximately 20% in premarket trading on March 12, 2026, following the company's Q4 fiscal 2026 earnings release after the close on March 11. The primary catalyst is not the earnings themselves — which beat expectations — but an imminent and massive lock-up expiration scheduled for March 13, 2026, when approximately 390 million shares of Class A common stock become eligible for public sale.
PATH shares fell approximately 10% in premarket trading on March 12, 2026, reversing the prior session's 6.82% gain, as investors digested Q4 fiscal 2026 earnings released after the close on March 11. The primary catalyst for the selloff was disappointing FY2027 revenue guidance, which implies approximately 8–9% top-line growth — a notable deceleration from the 13% growth delivered in FY2026.
TIC shares are down approximately 15% in premarket trading on March 12, 2026, ahead of the regular session open. Primary catalyst: TIC Solutions reported Q4 2025 earnings before market open, posting an adjusted loss of $0.25 per share — a miss of $0.33 against the analyst consensus of -$0.08 per share.
HIMX shares surged approximately +33% in premarket trading on March 12, 2026, with the stock climbing from a prior close of $9.15 to around $12.19–$12.56. The primary catalyst is a renewed wave of AI-driven semiconductor enthusiasm surrounding Himax's Co-Packaged Optics (CPO) technology and its potential role as a supplier to major players including NVIDIA and Taiwan Semiconductor Manufacturing.
GIII shares fell approximately 15.65% in early trading on March 12, 2026, after the company reported its fiscal Q4 and full-year 2026 earnings before the bell. Q4 net sales dropped 8.1% year-over-year to $771.5 million, missing Wall Street's consensus estimate of approximately $792 million.
LWLG shares surged approximately 42% in early trading on March 12, 2026, building on a 15% rally from the prior session, as the stock's multi-day momentum accelerated into the regular open. The primary catalyst is Lightwave Logic's newly announced silicon photonics development agreement with Tower Semiconductor (TSEM), integrating its electro-optic polymer modulator technology into Tower's PH18 platform.
IperionX (NASDAQ: IPX) shares fell approximately 15% in Thursday's session, with the ADR trading around $42.70 after closing at $50.26 the prior session. The primary catalyst was the company's half-year financial report (H1 FY2026, ending December 31, 2025), which revealed a sharply wider net loss of US$34.8 million — more than double the US$16.2 million loss reported in the prior corresponding period.
SITM shares are down approximately 10% in Thursday's trading session, extending a multi-week decline from February highs near $447. The primary catalyst is a broad-based semiconductor sector selloff driven by intensifying tariff fears and macro uncertainty under the Trump administration's escalating trade policy.
RHLD shares dropped over 24% today, accelerating a recent downtrend that had already left the stock roughly 15–17% lower over the past month before today’s earnings‑driven selloff. For 2025, Resolute reported sales of about $462 million, up modestly from the prior year, but its net loss widened to roughly $5.9 million versus a $2.3 million loss in 2024.
VEON shares fell more than 14% today, a sharp reversal that follows a 12‑month gain of roughly 120% and year‑to‑date return near 45%, leaving the stock vulnerable to profit‑taking.​ The move comes just one day before VEON is scheduled to release its Q4 and full‑year 2025 results, prompting pre‑earnings de‑risking from traders who had enjoyed substantial gains.​